{"paper_id":"9112b622-4a63-47ce-aa24-7ad12a0cd36d","body_text":"Abstract\nBackground\nLocal pro-inflammatory environment and enhanced cell survival contribute to the endometriosis development. A serine/threonine kinase p38 mitogen-activated protein kinase (MAPK) mediates intracellular signaling of cytokine production, cell proliferation, and apoptosis in different cell types. The current study compares p38 MAPK activity in normal endometrium and endometriosis, and assesses role(s) of p38 MAPK on cytokine production and cell survival in endometriosis.\nMethods\nImmu-nohistochemical levels of total and phosphorylated (active) p38 MAPK as well as its correlation with interleukin 8 (IL-8) expression, and cell proliferation and apoptosis were compared in normal human endometrium and endometriosis. The action of p38 MAPK on pro-inflammatory cytokine-induced IL-8 and monocyte chemotactic protein (MCP)-I expression in endometriotic cells were assessed by enzyme-linked immunosorbent assay. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell survival, 5-bromo-2’-deoxyuridine incorporation, and Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assays were used to determine the function of p38 MAPK in cultured human endometriotic stromal cell proliferation and apoptosis.\nResults\np38 MAPK activity was significantly higher in both eutopic and ectopic endometria compared to normal endometria during late proliferative and early secretory phases (P <.05). Increased p38 MAPK activity in endometriotic cells correlated with IL-8 expression (Pearson correlation coefficient r = 0.83, P <.01), but not with apoptosis in vivo. The proinflammatory cytokines IL-I (Band tumor necrosis factor (TNF)-a induced activation of p38 MAPK. Inhibition of p38 MAPK activity blocked IL-I (3 and TNF-a-induced IL-8 and MCP-I secretion in cultured endometriotic stromal cells (P <.05), but did not impact on endometriotic cell survival.\nConclusions\nThese results suggest that rather than modulating cell survival, increased p38 MAPK activity in endometriotic cells contributes to the pathogenesis of endometriosis by promoting the local inflammatory milieu.\nSimilar content being viewed by others\nReferences\nCakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A. Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed). 2009;1:429–443.\nOthman ER, Meligy FY, Sayed AA, El-Mokhtar MA, Refaiy AM. Stem cell markers describe a transition from somatic to pluripotent cell states in a rat model of endometriosis [Published online ahead of print]. ReprodSci. 2017:doi: 10.1177/1933719117697124.\nPluchino N, Taylor HS. Endometriosis and stem cell trafficking. Reprod Sci. 2016;23(12):1616–1619.\nGogacz M, Winkler I, Bojarska-Junak A, et al. Increased percentage of Thl7 cells in peritoneal fluid is associated with severity of endometriosis. J Reprod Immunol. 2016;117:39–44.\nJeung I, Cheon K, Kim MR. Decreased cytotoxicity of peripheral and peritoneal natural killer cell in endometriosis. Biomed Res Int. 2016;2016:2916070.\nSchatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22(4):497–515.\nUlukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig. 2006;13(7):467–476.\nWickstrom K, Stavreus-Evers A, Vercauteren O, Olovsson M, Edelstam G. Effect of lignocaine on IL-6, IL-8, and MCP-1 in peritoneal macrophages and endometriotic stromal cells. Reprod Sci. 2017;24(3):382–392.\nRakhila H, Al-Akoum M, Bergeron ME, et al. Promotion of angiogenesis and proliferation cytokines patterns in peritoneal fluid from women with endometriosis. J Reprod Immunol. 2016;116:1–6.\nKocbek V, Vouk K, Bersinger NA, Mueller MD, Lanisnik Rizner T. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis. J Mol Diagn. 2015;17(3):325–334.\nFakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril. 1987;47(2):213–217.\nMori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol. 1991;26(2):62–67.\nPellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simon C. The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril. 1998;70(3):425–431.\nArici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod. 1996;2(1):40–45.\nRyan IP, Tseng JF, Schriock ED, Khorram O, Landers DV, Taylor RN. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril. 1995; 63(4):929–932.\nArici A, Oral E, Attar E, Tazuke SI, Olive DL. Monocyte che-motactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril. 1997;67(6):1065–1072.\nYoung VJ, Ahmad SF, Brown JK, Duncan WC, Home AW. Peritoneal VEGF-A expression is regulated by TGF-betal through an ID1 pathway in women with endometriosis. Sci Rep. 2015;5: 16859.\nGarcia-Velasco JA, Arici A. Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin. Fertil Steril. 1999; 72(2):336–340.\nZhang RJ, Wild RA, Ojago JM. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril. 1993; 59(6):1196–1201.\nArici A. Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N YAcad Sci. 2002;955:101–109; discussion 118, 396–406.\nArici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J Clin Endocrinol Metab. 1998; 83(4):1201–1205.\nLebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-lbeta. Mol Hum Reprod. 2000; 6(3):269–275.\nGebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 1998;69(6):1042–1047.\nSong Y, Fu J, Zhou M, et al. Activated hippo/yes-associated protein pathway promotes cell proliferation and anti-apoptosis in endometrial stromal cells of endometriosis. J Clin Endocrinol Metab. 2016;101(4):1552–1561.\nDmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod. 2001;16(9):1802–1808.\nBeliard A, Noel A, Foidart JM. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril. 2004;82(1):80–85.\nHarada T, Taniguchi F, Izawa M, et al. Apoptosis and endometriosis. Front Biosci. 2007;12:3140–3151.\nKyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81(2):807–869.\nJohnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911–1912.\nOlson JM, Hallahan AR. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med. 2004;10(3):125–129.\nDelaney AA, Khan Z, Zheng Y, et al. KLF10 mediated epigenetic dysregulation of epithelial CD40/CD154 promotes endometriosis. Biol Reprod. 2016;95(3):62.\nYang RQ, Teng H, Xu XH, et al. Microarray analysis of micro-RNA deregulation and angiogenesis-related proteins in endometriosis [Published online ahead of print]. Genet Mol Res. 2016; 15(2). doi: 10.4238/gmr.l5027826.\nAu HK, Chang JH, Wu YC, et al. TGF-betal regulates cell migration through pluripotent transcription factor OCT4 in endometriosis. PLoS One. 2015;10(12):e0145256.\nSeval Y, Cakmak H, Kayisli UA, Arici A. Estrogen-mediated regulation of p38 mitogen-activated protein kinase in human endometrium. J Clin Endocrinol Metab. 2006;91(6):2349–2357.\nNoyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. AmJObstet Gynecol. 1975;122(2):262–263.\nYen CF, Liao SK, Huang SJ, et al. Decreased endometrial expression of leukemia inhibitory factor receptor disrupts the STAT3 signaling in adenomyosis during the implantation window. Reprod Sci. 2017;24(8):1176–1186.\nArici A, Head JR, MacDonald PC, Casey ML. Regulation of interleukin-8 gene expression in human endometrial cells in culture. Mol Cell Endocrinol. 1993;94(2):195–204.\nKayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A. Human chorionic gonadotropin contributes to maternal immuno-tolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol. 2003;171(5):2305–2313.\nSikora J, Mielczarek-Palacz A, Kondera-Anasz Z. Association of the precursor of interleukin-lbeta and peritoneal inflammation-role in pathogenesis of endometriosis. J Clin lab Anal. 2016; 30(6):831–837.\nTao Y, Zhang Q, Huang W, Zhu H, Zhang D, Luo W. The peritoneal leptin, MCP-1 and TNF-alpha in the pathogenesis of endometriosis-associated infertility. Am J Reprod Immunol. 2011;65(4):403–406.\nSukhikh GT, Sotnikova NY, Antsiferova YS, Posiseeva LV, Veryasov VN, Van’ko LV. Cytokine production by immunocompetent cells of peritoneal fluid in women with external genital endometriosis. Bull Exp Biol Med. 2004;137(6):568–571.\nRana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril. 1996; 65(5):925–930.\nSeli E, Guzeloglu-Kayisli O, Cakmak H, Kayisli UA, Selam B, Arici A. Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating Fas and Fas ligand expression. J Clin Endocrinol Metab. 2006;91(12):4995–5001.\nYeol SG, Won YS, Kim YI, Lee JW, Choi YJ, Park DC. Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis. Clin Exp Obstet Gynecol. 2015; 42(2):156–160.\nBorrelli GM, Kaufmann AM, Abrao MS, Mechsner S. Addition of MCP-1 and MIP-3beta to the IL-8 appraisal in peritoneal fluid enhances the probability of identifying women with endometriosis. JReprod Immunol. 2015;109:66–73.\nZhang L, Xiong W, Xiong Y, Liu H, Liu Y. 17 beta-Estradiol promotes vascular endothelial growth factor expression via the Wnt/beta-catenin pathway during the pathogenesis of endometriosis. Mol Hum Reprod. 2016;22(7):526–535.\nAhn JH, Choi YS, Choi JH. Leptin promotes human endometrio-tic cell migration and invasion by up-regulating MMP-2 through the JAK2/STAT3 signaling pathway. Mol Hum Reprod. 2015; 21(10):792–802.\nTosti C, Pinzauti S, Santulli P, Chapron C, Petraglia F. Pathogenetic mechanisms of deep infiltrating endometriosis. Reprod Sci. 2015;22(9):1053–1059.\nCarrarelli P, Funghi L, Ciarmela P, et al. Deep infiltrating endometriosis and endometrial adenocarcinoma express high levels of myostatin and its receptors messenger RNAs [Published online ahead of print]. Reprod Sci. 2017. doi: 10.1177/ 1933719117698579.\nMcKinnon BD, Kocbek V, Nirgianakis K, Bersinger NA, Mueller MD. Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics. Hum Reprod Update. 2016;22(3):382–403.\nChen S, Wu RF, Su L, Zhou WD, Zhu MB, Chen QH. Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17beta-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells. Fertil Steril. 2014; 102(1):264–271.\nHapangama DK, Turner MA, Drury JA, et al. Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. Hum Reprod. 2008;23(7):1511–1519.\nWatanabe A, Taniguchi F, Izawa M, et al. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum Reprod. 2009;24(12):3172–3179.\nHenkart PA, ICE family proteases: mediators of all apoptotic cell death? Immunity. 1996;4(3):195–201.\nJuo P, Kuo CJ, Reynolds SE, et al. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol. 1997;17(1):24–35.\nXia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270(5240):1326–1331.\nHuang S, Jiang Y, Li Z, et al. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity. 1997;6(6):739–749.\nNatale DR, Paliga AJ, Beier F, D’Souza SJ, Watson AJ. p38 MAPK signaling during murine preimplantation development. Dev Biol. 2004;268(1):76–88.\nLeconte M, Santulli P, Chouzenoux S, et al. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis. Reprod Sci. 2015;22(9):1171–1180.\nLi MQ, Shao J, Meng YH, et al. NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu. Hum Reprod. 2013;28(10):2822–2831.\nMao Y, Wang J, Yu F, et al. Ghrelin protects against palmitic acid or lipopolysaccharide-induced hepatocyte apoptosis through inhibition of MAPKs/iNOS and restoration of Akt/eNOS pathways. Biomed Pharmacother. 2016;84:305–313.\nChen NN, Wei F, Wang L, Cui S, Wan Y, Liu S. Tumor necrosis factor alpha induces neural stem cell apoptosis through activating p38 MAPK pathway. Neurochem Res. 2016;41(11):3052–3062.\nSantulli P, Marcellin L, Tosti C, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? Expert Opin Ther Targets. 2015;19(11):1465–1483.\nHuang Y, Li X, Wang Y, Wang H, Huang C, Li J. Endoplasmic reticulum stress-induced hepatic stellate cell apoptosis through calcium-mediated JNK/P38 MAPK and Calpain/Caspase-12 pathways. Mol Cell Biochem. 2014;394(1–2):1–12.\nCinar O, Seval Y, Uz YH, et al. Differential regulation of Akt phosphorylation in endometriosis. Reprod Biomed Online. 2009; 19(6):864–871.\nZheng Y, Khan Z, Zanfagnin V, Correa LF, Delaney AA, Daftary GS. Epigenetic modulation of collagen 1A1: therapeutic implications in fibrosis and endometriosis. Biol Reprod. 2016; 94(4):87.\nRichards EG, Zheng Y, Shenoy CC, et al. KLF11 is an epigenetic mediator of DRD2/dopaminergic signaling in endometriosis. Reprod Sci. 2017:24(8): 1129–1138.\nYoshino O, Osuga Y, Koga K, et al. FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J Reprod Immunol. 2006;72(1-2): 85–93.\nMcKinnon BD, Bertschi D, Bersinger NA, Mueller MD. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol Metab. 2015;26(1):1–10.\nDonaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med. 2007;25(6):461–475.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nCakmak, H., Seval-Celik, Y., Arlier, S. et al. p38 Mitogen-Activated Protein Kinase is Involved in the Pathogenesis of Endometriosis by Modulating Inflammation, but not Cell Survival. Reprod. Sci. 25, 587–597 (2018). https://doi.org/10.1177/1933719117725828\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1177/1933719117725828","source_license":"CC0","license_restricted":false}